Pubblicazioni 2013

  1. Arumugam P, Partelli S, Coleman SJ, Cataldo I, Beghelli S, Bassi C, Wijesuriya N, Aleong JA, Froeling FE, Scarpa A and Kocher HM. Ezrin Expression Is an Independent Prognostic Factor in Gastro-intestinal Cancers. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2013;17:2082-91.
  2. Bria E, De Manzoni G, Beghelli S, Tomezzoli A, Barbi S, Di Gregorio C, Scardoni M, Amato E, Frizziero M, Sperduti I, Corbo V, Brunelli M, Bersani S, Tortora G and Scarpa A. A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status. Ann Oncol. 2013;24:693-701.
  3. Brunelli M, Manfrin E, Bria E, Massari F, Tortora G, Brunello E, Carbognin L, Nottegar A, Furlanetto J, Molino A, Fiorio E, Chilosi M, Jasani B, Vergine M, Marcolini L, Filippini D, Scarpa A, Martignoni G and Bonetti F. HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy. Anticancer Res. 2013;33:3705-10.
  4. Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C, Talar-Wojnarowska R, Cantore M, Andriulli A, Scarpa A, Jamroziak K, Delle Fave G, Costello E, Khaw KT, Heller A, Key TJ, Theodoropoulos G, Malecka-Panas E, Mambrini A, Bambi F, Landi S, Pedrazzoli S, Bassi C, Pacetti P, Piepoli A, Tavano F, di Sebastiano P, Vodickova L, Basso D, Plebani M, Fogar P, Buchler MW, Bugert P, Vodicka P, Boggi U, Neoptolemos JP, Werner J and Canzian F. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2013;45:95-9.
  5. Campos ML, Sanchez-Arevalo Lobo VJ, Rodolosse A, Gottardi CJ, Mafficini A, Beghelli S, Scardoni M, Bassi C, Scarpa A and Real FX. ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. The Biochemical journal. 2013;451:395-405.
  6. Capdevila J, Meeker A, Garcia-Carbonero R, Pietras K, Astudillo A, Casanovas O and Scarpa A. Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets. Cancer metastasis reviews. 2013.
  7. Capello M, Cappello P, Linty FC, Chiarle R, Sperduti I, Novarino A, Salacone P, Mandili G, Naccarati A, Sacerdote C, Beghelli S, Bersani S, Barbi S, Bassi C, Scarpa A, Nistico P, Giovarelli M, Vineis P, Milella M and Novelli F. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. Journal of hematology & oncology. 2013;6:67.
  8. Cavallini C, Lovato O, Bertolaso A, Pacelli L, Zoratti E, Zanolin E, Krampera M, Zamo A, Tecchio C, Cassatella MA, Pizzolo G and Scupoli MT. The TNF-family cytokine TL1A inhibits proliferation of human activated B cells. PLoS One. 2013;8:e60136.
  9. Cesano A, Perbellini O, Evensen E, Chu CC, Cioffi F, Ptacek J, Damle RN, Chignola R, Cordeiro J, Yan XJ, Hawtin RE, Nichele I, Ware JR, Cavallini C, Lovato O, Zanotti R, Rai KR, Chiorazzi N, Pizzolo G and Scupoli MT. Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies. Haematologica. 2013;98:626-634.
  10. Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ and Biankin AV. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater. J Clin Oncol. 2013;31:1348-56.
  11. Chang DK, Jamieson NB, Scarpa A, McKay CJ and Biankin AV. Reply to G.F. Arroyo. J Clin Oncol. 2013;31:3843-4.
  12. Dalla Pozza E, Lerda C, Costanzo C, Donadelli M, Dando I, Zoratti E, Scupoli MT, Beghelli S, Scarpa A, Fattal E, Arpicco S and Palmieri M. Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity. Biochimica et biophysica acta. 2013;1828:1396-404.
  13. Di Costanzo F, Falconi M, Trodella L, Reni M and Scarpa A. Linee guida AIOM: Carcinoma del pancreas esocrino. AIOM document. 2013.
  14. Falco A, Rosati A, Festa M, Basile A, De Marco M, d’Avenia M, Pascale M, Dal Piaz F, Tavano F, Di Mola FF, di Sebastiano P, Berloco PB, Nudo F, Caraglia M, Febbraro A, Barcaroli D, Scarpa A, Pezzilli R, De Laurenzi V and Turco MC. BAG3 Is a Novel Serum Biomarker for Pancreatic Adenocarcinomas. The American journal of gastroenterology. 2013;108:1178-80.
  15. Fassan M, Simbolo M, Bria E, Mafficini A, Pilotto S, Capelli P, Bencivenga M, Pecori S, Luchini C, Neves D, Turri G, Vicentini C, Montagna L, Tomezzoli A, Tortora G, Chilosi M, De Manzoni G and Scarpa A. High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2013.
  16. Fazio N, Scarpa A and Falconi M. Molecular Targeted Therapy in Enteropancreatic Neuroendocrine Tumors: from Biology to Clinical Practice. Current medicinal chemistry. 2013.
  17. Giovinazzo F, Malpeli G, Zanini S, Parenti M, Piemonti L, Colombatti M, Valenti MT, Dalle Carbonare L, Scarpa A, Sinnett-Smith J, Rozengurt E, Bassi C and Innamorati G. Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction. Cellular signalling. 2013;25:651-9.
  18. Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S and Silvestris N. Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions. International journal of molecular sciences. 2013;14:19731-19762.
  19. Gruppo di lavoro AIOM – SIAPEC-IAP, Barbareschi M, Daidone MG, Lavitrano ML, Scarpa A, Pinto C, Clemente C, Ardizzoni A, Botti G, Bravo E, Adamo V, Marchetti A, Nappi N, Normanno N, Parodi B, Paradiso A, Passalacqua R, Santi L, Taddei GL, Stanta G, Tortora G, Truini M, Casati S, Lawlor RT and Macilotti M. Bio-banche oncologiche a scopo di ricerca: Definizione, finalità, organizzazione, requisiti strutturali e tecnologici, consenso informato, privacy e modalità di accesso. AIOM-SIAPEC document. 2013.
  20. Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJ, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, Tortora G, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N and Wood LD. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nature genetics. 2013;45:1470-3.
  21. Lawlor RT, Sluss PM, Langer R, Sughayer MA, Igbe MA, Siddiqui K, De Blasio P, Duma B, Mendy M, Chabannon C and Ibrahim M. European, Middle Eastern, and African Society for Biopreservation and Biobanking (ESBB). 2012 Conference Session on Biobanking in Emerging Countries. Biopreserv Biobank. 2013;11:176-81.
  22. Oberg K, Casanovas O, Castano JP, Chung D, Delle Fave G, Denefle P, Harris P, Khan MS, Kulke MH, Scarpa A, Tang LH and Wiedenmann B. Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches. Clin Cancer Res. 2013;19:2842-9.
  23. Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, Scarpa A, Ruszniewski P, Sauvanet A and Falconi M. Pattern and Clinical Predictors of Lymph Node Involvement in Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNETs). JAMA surgery. 2013;148:932-9.
  24. Pedica F, Ruzzenente A, Bagante F, Capelli P, Cataldo I, Pedron S, Iacono C, Chilosi M, Scarpa A, Brunelli M, Tomezzoli A, Martignoni G and Guglielmi A. A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse. PLoS One. 2013;8:e68203.
  25. Pilotto S, Bonomi M, Massari F, Milella M, Ciuffreda L, Brunelli M, Fassan M, Chilosi M, Scarpa A, Tortora G and Bria E. Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A ‘Hard Days Night’. Current pharmaceutical design. 2013.
  26. Rachakonda PS, Bauer AS, Xie H, Campa D, Rizzato C, Canzian F, Beghelli S, Greenhalf W, Costello E, Schanne M, Heller A, Scarpa A, Neoptolemos JP, Werner J, Buchler M, Hoheisel JD, Hemminki K, Giese N and Kumar R. Somatic mutations in exocrine pancreatic tumors: association with patient survival. PLoS One. 2013;8:e60870.
  27. Rosa R, Damiano V, Nappi L, Formisano L, Massari F, Scarpa A, Martignoni G, Bianco R and Tortora G. Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer. Br J Cancer. 2013;109:686-93.
  28. Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y and Croce CM. B-cell malignancies in microRNA Emu-miR-17~92 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:18208-13.
  29. Santos Franco S, De Falco L, Ghaffari S, Brugnara C, Sinclair DA, Matte A, Iolascon A, Mohandas N, Bertoldi M, An X, Siciliano A, Rimmele P, Cappellini MD, Michan S, Zoratti E, Janin A and De Franceschi L. Resveratrol accelerates erythroid maturation by activation of FOXO3 and ameliorates anemia in beta-thalassemic mice. Haematologica. 2013.
  30. Scarpa A, Fassan M, Rusev B, Luchini C and Capelli C. Pathologist’s role in the management of gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs). J Oncopathology. 2013;1:65-74.
  31. Scarpa A, Sikora K, Fassan M, Rachiglio AM, Cappellesso R, Antonello D, Amato E, Mafficini A, Lambiase M, Esposito C, Bria E, Simonato F, Scardoni M, Turri G, Chilosi M, Tortora G, Fassina A and Normanno N. Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel. PLoS One. 2013;8:e80478.
  32. Simbolo M, Gottardi M, Corbo V, Fassan M, Mafficini A, Malpeli G, Lawlor RT and Scarpa A. DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One. 2013;8:e62692.